BioNxt Solutions Inc.
BNXT
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.90% | 31.69% | -48.45% | 13.77% | -50.93% |
| Total Depreciation and Amortization | -18.37% | 219.51% | -125.15% | -3.55% | 1.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.88% | -62.30% | 173.80% | -16.84% | 44.24% |
| Change in Net Operating Assets | -676.18% | 134.88% | -108.56% | -125.17% | 906.22% |
| Cash from Operations | -168.53% | 40.22% | -18.30% | -358.46% | 68.38% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 2,615.38% | -97.76% | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -176.92% | -97.76% | -- | -- | -100.00% |
| Total Debt Issued | -- | -100.00% | 60.66% | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | 214.37% | 219.63% | -2.10% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -106.73% | 185.54% | -1,021.17% | -- | 100.00% |
| Cash from Financing | 480.06% | -70.71% | 43.79% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -100.00% | 200.00% | -71.43% | 250.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 243.65% | -213.54% | 706.45% | 79.74% | -201.45% |